Cargando…
Do we really need more evidence to use hepatitis C positive donor kidney more liberally?
The number of patients listed active for kidney transplantation has continued to rise over the last 10 years, leading to significantly increased wait-list time for patients awaiting kidney transplantation in the USA. This increased demand has led to a supply–demand mismatch and should prompt clinici...
Autores principales: | Joglekar, Kiran, Eason, James D., Molnar, Miklos Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561329/ https://www.ncbi.nlm.nih.gov/pubmed/28835817 http://dx.doi.org/10.1093/ckj/sfx067 |
Ejemplares similares
-
Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023) -
Antioxidants in Pregnancy: Do We Really Need More Trials?
por: Di Fabrizio, Carolina, et al.
Publicado: (2022) -
Therapeutic Donor Kidney Transplant Outcomes: Comparing Early US Experiences Using Optimal Matching
por: Yamauchi, Junji, et al.
Publicado: (2023) -
ResearchAbility: do we really need a more inclusive environment in research?
por: Greco, Gian Maria
Publicado: (2021) -
Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes
por: Cohen, Jordana B., et al.
Publicado: (2017)